CAMPBELL, Calif., July 23, 2025--(BUSINESS WIRE)--Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and first patient cases with the latest advancement in ...
SAN RAMON, Calif., and VILNIUS, Lithuania, BioVentrix, a pioneer of technologies and procedures for less-invasive treatment of heart failure (HF), today announced the first-in-man use of its next ...
MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval for use, and the first patient procedure using the Achieve™ Mapping ...
Distraction methods, such as use of a stress ball, are simple and effective strategies for reducing perceived stress and pain in patients during port catheter needle insertion. Distraction methods are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback